Literature DB >> 16624535

Galanin enhances and a galanin antagonist attenuates depression-like behaviour in the rat.

Eugenia Kuteeva1, Tara Wardi, Tomas Hökfelt, Sven Ove Ogren.   

Abstract

The effect of intracerebroventricular infusion of galanin and/or the galanin antagonist M35 was studied in the forced swim test. Animals were pre-exposed to water for 15 min 24 h prior to test. Immobility and climbing were assessed during the second, 5 min exposure to water. Rats receiving a single infusion of galanin (3 nmol) displayed a significant increase of immobility. This effect was blocked by co-administration of M35 (1 nmol). M35 alone (1 nmol) produced a significant decrease of immobility. The results further support the hypothesis that galanin may play a role in mood disorders, and that galanin antagonists may represent new candidates for antidepressant treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16624535     DOI: 10.1016/j.euroneuro.2006.03.003

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  11 in total

1.  GAL3 receptor KO mice exhibit an anxiety-like phenotype.

Authors:  Susanne M Brunner; Aitak Farzi; Felix Locker; Barbara S Holub; Meinrad Drexel; Florian Reichmann; Andreas A Lang; Johannes A Mayr; Jorge J Vilches; Xavier Navarro; Roland Lang; Günther Sperk; Peter Holzer; Barbara Kofler
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-29       Impact factor: 11.205

Review 2.  Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.

Authors:  Sven Ove Ogren; Eugenia Kuteeva; Tomas Hökfelt; Jan Kehr
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 3.  Dysfunctional Heteroreceptor Complexes as Novel Targets for the Treatment of Major Depressive and Anxiety Disorders.

Authors:  Miguel Pérez de la Mora; Dasiel O Borroto-Escuela; Minerva Crespo-Ramírez; José Del Carmen Rejón-Orantes; Daniel Alejandro Palacios-Lagunas; Magda K Martínez-Mata; Daniela Sánchez-Luna; Emiliano Tesoro-Cruz; Kjell Fuxe
Journal:  Cells       Date:  2022-06-02       Impact factor: 7.666

Review 4.  Neuropeptide and sigma receptors as novel therapeutic targets for the pharmacotherapy of depression.

Authors:  Konstantinos A Paschos; Stavroula Veletza; Ekaterini Chatzaki
Journal:  CNS Drugs       Date:  2009-09       Impact factor: 5.749

5.  Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests.

Authors:  Xiaoying Lu; Brendon Ross; Manuel Sanchez-Alavez; Eric P Zorrilla; Tamas Bartfai
Journal:  Neuropeptides       Date:  2008-06-12       Impact factor: 3.286

Review 6.  Depression and antidepressants: molecular and cellular aspects.

Authors:  Cristina Lanni; Stefano Govoni; Adele Lucchelli; Cinzia Boselli
Journal:  Cell Mol Life Sci       Date:  2009-06-12       Impact factor: 9.261

7.  Differential activity by polymorphic variants of a remote enhancer that supports galanin expression in the hypothalamus and amygdala: implications for obesity, depression and alcoholism.

Authors:  Scott Davidson; Marissa Lear; Lynne Shanley; Benjamin Hing; Amanda Baizan-Edge; Annika Herwig; John P Quinn; Gerome Breen; Peter McGuffin; Andrew Starkey; Perry Barrett; Alasdair MacKenzie
Journal:  Neuropsychopharmacology       Date:  2011-06-29       Impact factor: 7.853

8.  Altered gene expression profiles in the hippocampus and prefrontal cortex of type 2 diabetic rats.

Authors:  Omar Abdul-Rahman; Maria Sasvari-Szekely; Agota Ver; Klara Rosta; Bernadett K Szasz; Eva Kereszturi; Gergely Keszler
Journal:  BMC Genomics       Date:  2012-02-27       Impact factor: 3.969

9.  A role for galanin N-terminal fragment (1-15) in anxiety- and depression-related behaviors in rats.

Authors:  Carmelo Millón; Antonio Flores-Burgess; Manuel Narváez; Dasiel O Borroto-Escuela; Luis Santín; Concepción Parrado; José Angel Narváez; Kjell Fuxe; Zaida Díaz-Cabiale
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

10.  Mirtazapine may show anti-hyperglycemic effect by decreasing GLUT2 through leptin and galanin expressions in the liver of type 1 diabetic rats.

Authors:  Ezgi Bektur; Erhan Sahin; Cengiz Baycu
Journal:  Iran J Basic Med Sci       Date:  2019-06       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.